Cerliponase alfa 150mg/5ml solution for infusion vials

SNOMED code
35813511000001103
Active compound
Cerliponase alfa
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
5 ml, vial
Ingredients
Cerliponase alfa — 30 mg / 1 ml based on ingredient substance
Form & Route
solutioninfusion.intracerebroventricular
Solution for infusion, Intracerebroventricular
Controlled drug
No Controlled Drug Status

Products

Brineura 150mg/5ml solution for infusion vials (BioMarin (U.K.) Ltd)

Brineura 150mg/5ml solution for infusion vials

SNOMED code
35813711000001108
Supplier
BioMarin (U.K.) Ltd
Licensed as
Medicines - MHRA/EMA
EMA (European Medicines Agency) Monitoring
Yes, black triangle marked
Availability restrictions
None
Licensed route
Intracerebroventricular
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Brineura 150mg/5ml solution for infusion vials (BioMarin (U.K.) Ltd) 2 vial
35813811000001100   ref. pack
💯 Available

Legal category: POM
05391524461060

End: 05391524461985
NHS Indicative Price
£20,107
• Hospital
  • • Prescription Charges

Reference packs

Cerliponase alfa 150mg/5ml solution for infusion vials 2 vial
SNOMED code
35813611000001104
Quantity and unit
2 vial
Packs